Gut health plays a bigger role in your overall well-being than many people realize
Lancet 383(9911):3139 Tabernero J et al (2015) Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Donnerstag, B., Ohlenschlager, G., Cinatl, J., et al
In our study, PFD did not inhibit fibrosis significantly, which was possibly due to the short duration of the medication (with normal dosing involving 6 weeks of administration in a mouse model and 3-6 months in clinical trials 19,42,43 )
The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model